It was suggested that this PPARα deletion worsened eosinophilia and asthma-like symptoms by preventing the anti-inflammatory actions mediated by the endogenous PPARα ligand, LTB4, known to be produced abundantly by mast cells and other cell types in asthma. The gene discussed is PPARA; the disease is Increased total eosinophil count.